Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

KYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/KYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

KYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSION

Amgen Europe B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 9, 2025
Approval ID: 7e293ca585d3a246
Company: Amgen Europe B.V.
Type: Standard

Approval Details

Approval Id: 7e293ca585d3a246
Drug Cima Aemps Name: KYPROLIS 30 MG POLVO PARA SOLUCION PARA PERFUSION
Register Number: 1151060003IP
Holder Company Name: Amgen Europe B.V.
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/4baeda6441d44a3b/amgen-europe-b-v
Authorization Date: 2025-04-09
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE
Dose: 30 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Amgen Europe B.V.
Company Detail Path: /organization/4baeda6441d44a3b/amgen-europe-b-v

Company Information

Pharmaceutical Company Name: AMGEN EUROPE B.V.
Country Name: Israel
City Name: tel aviv-jaffa,central district,country_il
Address: Simtat Maoz

Active Ingredients

CARFILZOMIB

30 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 9, 2025

Approval ID

7e293ca585d3a246

Type

Standard

Back to CIMA-AEMPS Approvals